Use of GM-CSF in children after high-dos
โ
Furman, Wayne L. ;Fairclough, Diane ;Cain, Alvida M. ;Arnold, Bettye A. ;Pratt,
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 397 KB
The toxicity and efficacy of recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) is established in adults, but limited information is available on its use in children. The profound myelotoxicity induced by cisplatin (40 mg/m2 daily x 5) and etoposide (150 mg/m2 daily x 3)